Trial Profile
BAIL-OUT: 'Bail-out Anticoagulation in coronary Intervention TriaL - OUTcomes': a randomised comparison of the real world use of bivalirudin versus abciximab as a 'bail out' anticoagulant following heparin in percutaneous coronary intervention with focus on patient safety
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2021
Price :
$35
*
At a glance
- Drugs Bivalirudin (Primary) ; Abciximab; Heparin
- Indications Coronary artery disease; Coronary thrombosis
- Focus Adverse reactions
- Acronyms BAIL-OUT
- 17 Apr 2007 New trial record.